Collateral for a security interest recorded Aug 4, 2022 (Heritage Bank of Commerce).
Term ends Apr 9, 2035 · High confidence
20-year base term ends Jan 6, 2037
Held by Vivex Biologics Group, Inc.
Filed Oct 15, 2020 as application 17/071,599 · Granted Mar 21, 2023
Base term plus 288 days of patent term adjustment (USPTO delay) · capped by a resolved terminal disclaimer
Today
2017
2037
Clock starts
Jan 6, 2017
Jan 6, 2017
Term ends
Apr 9, 2035
Apr 9, 2035
Granted
Mar 21, 2023
Mar 21, 2023
base term
after the term ends
fee events
Updated Nov 21, 2026 · includes USPTO assignment data published Nov 20, 2026, status data published Nov 21, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
288
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
Capped
Terminal disclaimer
Resolved from the filed document, referencing US 11,324,215, US 12,226,532.
1 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain, as the file histories and patent records this site holds name them. The family may have others.
This patent's term runs 288 days past its 20-year base term on prosecution delay. A terminal disclaimer resolved from the filed document caps it earlier. 1 of 3 maintenance fees is paid so far. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Jan 6, 2017, when application 15/400,392, the earliest non-provisional in its chain, was filed (this one was filed Oct 15, 2020) | Jan 6, 2037 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +288 days, USPTO patent term adjustment record | Oct 21, 2037 | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 11,324,215, US 12,226,532) | capped to Apr 9, 2035 | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 1 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Apr 9, 2035 | High confidence |
This family
| US 10,645,921 | In force Jan 2037 | Jan 2037 |
| US 11,324,215 | In force May 2038 | May 2038 |
| US 11,606,953 | this patent Apr 2035 | Apr 2035 |
| Application 17/487,618 | Pending not computed | not computed |
| Application 19/024,212 | Pending not computed | not computed |
Every application listed has its file history here. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Nov 2, 2020 Reel 54241, frame 716 | Temple, Harry Thomas; Ganey, Timothy; Gonzalez, Stephanie; Anderson, Tracy Scott; Namin, Shabnam | Vivex Biomedical, Inc. | Assignment of Assignor's Interest |
| Nov 2, 2020 Reel 54278, frame 128 | Vivex Biomedical, Inc. | Vivex Biologics, Inc. | Change of Name |
| Nov 2, 2020 Reel 54279, frame 730 | Vivex Biologics, Inc. | Vivex Biologics Group, Inc. | Change of Name |
| Aug 4, 2022 Reel 61084, frame 607 | Vivex Biologics Group, Inc. | Heritage Bank of Commerce | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Apr 2035
Term ends Apr 9, 2035. Maintenance fees still fall due before then
Note
The 288 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Disclaimer cap
This term is capped by a terminal disclaimer resolved from the filed document, referencing US 11,324,215, US 12,226,532.
Citations
0
later US patents cite this one
That is below the median of utility patents granted in 2023 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.